SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Foley Trasimene Acquisition Corp. (WPF) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 23/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — WPF
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.01 |
$2.26B |
$126M |
5.6% |
| 2017 |
$0.19 |
$2.3B |
$24M |
1% |
| 2018 |
$-0.05 |
$2.38B |
$-21M |
-0.9% |
| 2019 |
$0.05 |
$2.55B |
$22M |
0.9% |
| 2020 |
$-0.23 |
$2.73B |
$-103M |
-3.8% |
| 2021 |
$-0.14 |
$2.92B |
$-60M |
-2.1% |
| 2022 |
$-0.13 |
$3.13B |
$-62M |
-2% |
| 2023 |
$-0.70 |
$3.41B |
$-345M |
-10.1% |
| 2024 |
$-0.29 |
$2.33B |
$-157M |
-6.7% |
| 2025 |
$0.00 |
$2.26B |
$-3.1B |
-136.9% |
